The FDA advised IO Biotech last year to hold off on filing an approval application for its cancer vaccine Cylembio, pointing to a failed Phase 3 study in frontline advanced melanoma. The biotech has ...
Apollo.io, a leading artificial intelligence (AI)-native go-to-market platform, has acquired Pocus, an enterprise-grade revenue intelligence platform that helps teams turn buying signals into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results